-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Orchard Therapeutics plc quarterly/annual Costs and Expenses history and growth rate from Q1 2018 to Q3 2023.
- Orchard Therapeutics plc Costs and Expenses for the quarter ending September 30, 2023 was $27.9M, a 10.7% decline year-over-year.
- Orchard Therapeutics plc Costs and Expenses for the twelve months ending September 30, 2023 was $124M, a 16.3% decline year-over-year.
- Orchard Therapeutics plc annual Costs and Expenses for 2022 was $150M, a 5.37% increase from 2021.
- Orchard Therapeutics plc annual Costs and Expenses for 2021 was $142M, a 10.9% decline from 2020.
- Orchard Therapeutics plc annual Costs and Expenses for 2020 was $160M, a 9.02% decline from 2019.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)